Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
NCT05563168
Study Evaluating Diltiazem in Combination With Standard Treatment in the Management of Patients Hospitalized With COVID-19 Pneumonia
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2023
Completion: Dec 31, 2024